Summary
A powerful new weapon could one day join the global fight against malaria, especially to help people who need temporary protection from the deadly disease. Drugs and bed nets can to some extent already protect against the disease, which still sickens at least 200 million people a year and kills an estimated 400,000. Vaccines have also shown some promise. But an unusual study reported last week dramatized the potential of monoclonal antibodies, made by genetically engineered cells. Nine volunteers who received the antibodies were deliberately exposed to mosquitoes carrying the parasite that causes malaria. None became infected—and the protection from the antibodies appears to last for more than 6 months.
"term" - Google News
August 20, 2021 at 01:08AM
https://ift.tt/3AV35Y3
Antibody acts like short-term malaria vaccine - Science Magazine
"term" - Google News
https://ift.tt/35lXs52
https://ift.tt/2L1ho5r
Bagikan Berita Ini
0 Response to "Antibody acts like short-term malaria vaccine - Science Magazine"
Post a Comment